Published in Lab Law Weekly, November 11th, 2005
The aim of Digna Biotech is the development CIMA intellectual property at the University of Navarre on pre-clinical, clinical and commercial levels.
This p144 designation mean a series of advantages for the clinical development that Digna...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.